CTSU R0924 Skip To Content

Study ID: CTSU R0924


Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy on the prostate gland and seminal vesicles with hormone therapy and radiation therapy to the whole pelvic body area on a participant to find out which is better. Participants in this study have been diagnosed with unfavorable intermediate or favorable high risk prostate cancer.
Bemidji Clinic, Fargo Region, Sioux Falls Region
Principal Investigator:
Miroslaw Mazurczak, MD,Preston Steen, MD,Preston Steen, MD
Phase III
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.